STOCKHOLM–(BUSINESS WIRE)–Regualtory News: Tobii AB plans to publish the interim report for the period January 1—June 30 on July 28 at 08.00 CET. Following this report Tobii will arrange a conference call with web cast presentation for investors, analysts and media. Tobii’s President and CEO Henrik Eskilsson and CFO Esben Olesen will present and comment on the report. After the presentation there will be time for questions. The presentation will be held in English. Time Thursday, July 28, 201
An ultrahigh-speed cut rate 25-gauge system can significantly reduce core vitrectomy time in eyes undergoing vitreoretinal surgery when compared with a standard cut rate 25-gauge system, according to a study.Sixty-two eyes were evaluated in the single-…
The United States “will be better off” due to the progress that the Affordable Care Act has made in addressing inadequacies in the health care system, according to a special communication issued by President Barack Obama, JD.Published in JAMA, Presiden…
CMS recently proposed changes to the Physician Fee Schedule to modify how Medicare pays for primary care, focusing on care management and behavioral health.“Today’s proposals are intended to give a significant lift to the practice of primary care and to boost the time a physician can spend with their patients listening, advising and coordinating their care — both for physical and mental health,” CMS Acting Administrator Andrew Slavitt, said in a press release. “If this rule is finalized, it will put our nation’s money where its mouth is by continuing (Read more...)
LEXINGTON, Mass–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced the initiation of a Phase 2 dose-ranging trial of a fixed-dose combination (FDC) of trabodenoson and latanoprost.
This video shows a new approach to scleral buckling for retinal detachment surgery, “easier and faster to learn and to perform also by young vitreoretinal surgeons with little or no experience in indirect ophthalmoscopy,” according to Omar Trabelsi, MD.No indirect ophthalmoscope or a three-mirror lens and slit lamp are used. The whole procedure is performed under a microscope with a wide-angle viewing lens (BIOM, Oculus), using a vitrectomy endolight inserted through a 25-gauge trocar.